These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 15114077

  • 1. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
    Barten MJ, Streit F, Boeger M, Dhein S, Tarnok A, Shipkova M, Armstrong VW, Mohr FW, Oellerich M, Gummert JF.
    Transplantation; 2004 Apr 27; 77(8):1154-62. PubMed ID: 15114077
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolic acid interaction with cyclosporine and tacrolimus in vitro and in vivo: evaluation of additive effects on rat blood lymphocyte function.
    Barten MJ, Shipkova M, Bartsch P, Dhein S, Streit F, Tarnok A, Armstrong VW, Mohr FW, Oellerich M, Gummert JF.
    Ther Drug Monit; 2005 Apr 27; 27(2):123-31. PubMed ID: 15795640
    [Abstract] [Full Text] [Related]

  • 3. Assessment of immunosuppressive drug interactions: inhibition of lymphocyte function in peripheral human blood.
    Barten MJ, Dhein S, Chang H, Bittner HB, Tarnok A, Rahmel A, Mohr FW, Gummert JF.
    J Immunol Methods; 2003 Dec 27; 283(1-2):99-114. PubMed ID: 14659903
    [Abstract] [Full Text] [Related]

  • 4. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT, Ottosen P, Starklint H, Dieperink H.
    Nephrol Dial Transplant; 2003 Mar 27; 18(3):491-6. PubMed ID: 12584269
    [Abstract] [Full Text] [Related]

  • 5. Modeling individual variation in biomarker response to combination immunosuppression with stimulated lymphocyte responses-potential clinical implications.
    Sindhi R, Allaert J, Gladding D, Haaland P, Koppelman B, Dunne J, Sehgal S.
    J Immunol Methods; 2003 Jan 15; 272(1-2):257-72. PubMed ID: 12505729
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1.
    Bai S, Brunner LJ, Stepkowski SM, Napoli KL, Kahan BD.
    Transplantation; 2001 Jun 15; 71(11):1585-92. PubMed ID: 11435969
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacodynamic monitoring of the conversion of cyclosporine to tacrolimus in heart and lung transplant recipients.
    Barten MJ, Rahmel A, Garbade J, Bold A, Bittner HB, Dhein S, Mohr FW, Gummert JF.
    Transplant Proc; 2005 Dec 15; 37(10):4532-4. PubMed ID: 16387162
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat: evidence for pharmacokinetic interactions.
    Napoli KL, Wang ME, Stepkowski SM, Kahan BD.
    Ther Drug Monit; 1998 Apr 15; 20(2):123-33. PubMed ID: 9558125
    [Abstract] [Full Text] [Related]

  • 15. Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro.
    Barten MJ, Gummert JF, van Gelder T, Shorthouse R, Morris RE.
    J Immunol Methods; 2001 Jul 01; 253(1-2):95-112. PubMed ID: 11384672
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preclinical results of sirolimus treatment in transplant models.
    Stepkowski SM.
    Transplant Proc; 2003 May 01; 35(3 Suppl):219S-226S. PubMed ID: 12742499
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses.
    Berry V, Magill A, Yost M, Janosky J, Sindhi R.
    Cytometry A; 2006 Feb 01; 69(2):95-103. PubMed ID: 16369935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.